These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Genetic testing by cancer site: pancreas. Axilbund JE; Wiley EA Cancer J; 2012; 18(4):350-4. PubMed ID: 22846737 [TBL] [Abstract][Full Text] [Related]
5. Familial Pancreatic Cancer and the Future of Directed Screening. Welinsky S; Lucas AL Gut Liver; 2017 Nov; 11(6):761-770. PubMed ID: 28609837 [TBL] [Abstract][Full Text] [Related]
6. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Canto MI; Goggins M; Hruban RH; Petersen GM; Giardiello FM; Yeo C; Fishman EK; Brune K; Axilbund J; Griffin C; Ali S; Richman J; Jagannath S; Kantsevoy SV; Kalloo AN Clin Gastroenterol Hepatol; 2006 Jun; 4(6):766-81; quiz 665. PubMed ID: 16682259 [TBL] [Abstract][Full Text] [Related]
7. Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance. Kluijt I; Cats A; Fockens P; Nio Y; Gouma DJ; Bruno MJ J Clin Gastroenterol; 2009 Oct; 43(9):853-7. PubMed ID: 19417680 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic adenocarcinoma in a patient with Peutz-Jeghers syndrome: report of a case and literature review. Hirao S; Sho M; Kanehiro H; Hisanaga M; Ikeda N; Tsurui H; Nakajima Y; Nakano H Hepatogastroenterology; 2000; 47(34):1159-61. PubMed ID: 11020903 [TBL] [Abstract][Full Text] [Related]
9. Familial pancreatic cancer: Concept, management and issues. Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467 [TBL] [Abstract][Full Text] [Related]
10. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms. Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310 [TBL] [Abstract][Full Text] [Related]
11. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Poley JW; Kluijt I; Gouma DJ; Harinck F; Wagner A; Aalfs C; van Eijck CH; Cats A; Kuipers EJ; Nio Y; Fockens P; Bruno MJ Am J Gastroenterol; 2009 Sep; 104(9):2175-81. PubMed ID: 19491823 [TBL] [Abstract][Full Text] [Related]
12. Current Approaches to Pancreatic Cancer Screening. Chhoda A; Lu L; Clerkin BM; Risch H; Farrell JJ Am J Pathol; 2019 Jan; 189(1):22-35. PubMed ID: 30558719 [TBL] [Abstract][Full Text] [Related]
13. Early detection of pancreatic cancer: why, who, and how to screen. Klapman J; Malafa MP Cancer Control; 2008 Oct; 15(4):280-7. PubMed ID: 18813195 [TBL] [Abstract][Full Text] [Related]
14. Promising outcomes of screening for pancreatic cancer by genetic testing and endoscopic ultrasound. Sud A; Wham D; Catalano M; Guda NM Pancreas; 2014 Apr; 43(3):458-61. PubMed ID: 24622079 [TBL] [Abstract][Full Text] [Related]
15. Development of a high risk pancreatic screening clinic using 3.0 T MRI. Barnes CA; Krzywda E; Lahiff S; McDowell D; Christians KK; Knechtges P; Tolat P; Hohenwalter M; Dua K; Khan AH; Evans DB; Geurts J; Tsai S Fam Cancer; 2018 Jan; 17(1):101-111. PubMed ID: 29101607 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection. Becker AE; Hernandez YG; Frucht H; Lucas AL World J Gastroenterol; 2014 Aug; 20(32):11182-98. PubMed ID: 25170203 [TBL] [Abstract][Full Text] [Related]